Marinus Pharmaceuticals, Inc. (MRNS) Social Stream
MARINUS PHARMACEUTICALS INC (MRNS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MARINUS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-06 | 9 | $40 | $20 | $31 | $10.26 | 202.14% |
| 2022-02-02 | 9 | $40 | $20 | $30.75 | $10.26 | 199.71% |
| 2022-02-22 | 9 | $38 | $20 | $30.125 | $10.26 | 193.62% |
| 2022-02-23 | 9 | $38 | $17 | $29.428 | $10.26 | 186.82% |
| 2022-03-23 | 8 | $50 | $17 | $32.166 | $10.26 | 213.51% |
| 2022-03-28 | 8 | $50 | $17 | $31.142 | $10.26 | 203.53% |
| 2022-04-01 | 8 | $50 | $17 | $31.143 | $10.26 | 203.54% |
| 2022-05-17 | 8 | $50 | $17 | $31.571 | $10.26 | 207.71% |
| 2022-08-12 | 8 | $50 | $17 | $31 | $10.26 | 202.14% |
| 2022-10-31 | 8 | $50 | $17 | $30.285 | $10.26 | 195.18% |
| 2022-11-09 | 9 | $50 | $17 | $28.714 | $10.26 | 179.86% |
| 2022-11-14 | 9 | $50 | $12 | $25.875 | $10.26 | 152.19% |
| 2023-01-23 | 7 | $50 | $12 | $25.375 | $10.26 | 147.32% |
| 2023-03-08 | 8 | $50 | $12 | $25.375 | $10.26 | 147.32% |
| 2023-04-20 | 10 | $50 | $12 | $25 | $10.26 | 143.66% |
| 2023-04-25 | 10 | $50 | $14 | $25.222 | $10.26 | 145.83% |
| 2023-05-15 | 11 | $42 | $14 | $24.333 | $10.26 | 137.16% |
| 2023-07-11 | 11 | $42 | $14 | $23.7 | $10.26 | 130.99% |
| 2023-08-11 | 11 | $32 | $14 | $22.7 | $10.26 | 121.25% |
| 2023-09-19 | 11 | $32 | $9 | $20.9 | $10.26 | 103.7% |
| 2023-09-21 | 11 | $32 | $9 | $21.2 | $10.26 | 106.63% |
| 2023-11-08 | 11 | $28 | $9 | $20.3 | $10.26 | 97.86% |
The Trend in the Analyst Price Target
MRNS's average price target has moved down $9.75 over the prior 23 months.
MRNS reports an average of 224.92% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-23 | 9 | 50 | 12 | 25.375 | 5.650 | 349.12% |
| 2023-01-23 | 7 | 50 | 12 | 25.375 | 5.650 | 349.12% |
| 2023-05-15 | 11 | 42 | 14 | 24.333 | 8.620 | 182.29% |
| 2023-08-11 | 11 | 32 | 9 | 22.200 | 6.820 | 225.51% |
| 2023-11-08 | 11 | 28 | 9 | 20.300 | 6.895 | 194.42% |
MRNS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.27 | 9 | 1 | 1 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
MRNS's average broker recommendation rating worsened by 0.27 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how MARINUS PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2525.23% of that group.
- To contextualize these metrics, consider that out of all US stocks, MARINUS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2537.3% of them.
- In terms of how MARINUS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2808.02% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, MARINUS PHARMACEUTICALS INC's average analyst price target is higher than 2019.23% of them.
Stocks similar to MARINUS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AKBA, OCUL, and CRBP.
View All Top Stocks by Price Target
Make investment decisions regarding MRNS using the data that counts. Try POWR Ratings for free.